Related Experiment Video
Updated: Dec 11, 2025
Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
Published on: August 11, 2023
Cherry angioma: A case-control study.
Ramah I Nazer1, Rahaf H Bashihab2, Wedad H Al-Madani3
1Department of Medicine, Division of Dermatology, College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Tamsulosin may increase cherry angioma risk, while clopidogrel appears to protect against their development. Further research is needed to confirm these associations for common vascular skin lesions.
Area of Science:
- Dermatology
- Vascular Lesions
- Epidemiology
Background:
- Cherry angiomas (CAs) are common, asymptomatic vascular skin lesions.
- Limited research exists on CA risk factors.
Purpose of the Study:
- To identify risk factors associated with the development of cherry angiomas.
Main Methods:
- A case-control study was conducted with 300 participants (100 cases, 200 controls).
- Data on demographics, medical history, and medications were collected from electronic records.
Main Results:
- Tamsulosin use was independently associated with an increased risk of CAs (OR = 3.475, P = 0.009).
- Clopidogrel use was independently associated with a reduced risk of CAs (OR = 0.281, P = 0.028).
- Benign prostatic hyperplasia and malignancy showed associations but did not reach statistical significance in multivariate analysis.
Conclusions:
- Tamsulosin is a potential risk factor for cherry angioma development.
- Clopidogrel may play a protective role in preventing cherry angiomas.
More Related Videos
05:31Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
Published on: September 20, 2020
10:24Detecting Abnormalities in Choroidal Vasculature in a Mouse Model of Age-related Macular Degeneration by Time-course Indocyanine Green Angiography
Published on: February 19, 2014